Determinants of Quality of Life in Patients with Atopic Dermatitis and Psoriasis: A Multivariate Approach
DOI:
https://doi.org/10.2340/actadv.v105.42794Keywords:
atopic dermatitis, cardiometabolic comorbidities, health behaviors, health-related quality of life, psoriasis, psychological factorsAbstract
Health-related quality of life (HRQoL) is reduced in atopic dermatitis and psoriasis. Several factors impact HRQoL including sociodemographic and skin disease-related characteristics, health behaviours, cardiometabolic comorbidities, and psychological conditions. However, their differential and unique effects on HRQoL are not well studied. In this cross-sectional online survey, adult patients with atopic dermatitis (n = 155) or psoriasis (n = 246) provided data on features of their respective skin diseases, health behaviours, and cardiometabolic comorbidities. Validated self-report measures assessed HRQoL, psychopathology (Patient Health Questionnaire-4), and stress (Perceived Stress Scale). Linear regression analyses were used to determine key predictors of HRQoL. In atopic dermatitis, linear regression analyses revealed that self-rated disease severity (Patient-Oriented Eczema Measure), anxiety, and stress were significant predictors of the Dermatology Life Quality Index (DLQI), explaining 59% of the variance. In psoriasis, disease severity (Psoriasis Symptoms and Signs Diary) and depression significantly predicted DLQI, with an explained variance of 57%. Health behaviours and cardiometabolic comorbidities did not impact DLQI scores. While skin disease severity is the most important determinant of HRQoL, stress and anxiety are important in atopic dermatitis, whereas depression is relevant in psoriasis. These findings hold implications for both clinical practice and research.
Downloads
References
Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM; Global Psoriasis Atlas. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ 2020; 369: m1590.
https://doi.org/10.1136/bmj.m1590 DOI: https://doi.org/10.1136/bmj.m1590
Raimondo A, Lembo S. Atopic dermatitis: epidemiology and clinical phenotypes. Dermatol Pract Concept 2021; 11: e2021146.
https://doi.org/10.5826/dpc.1104a146 DOI: https://doi.org/10.5826/dpc.1104a146
Cortés H, Rojas-Márquez M, Del Prado-Audelo ML, Reyes-Hernández OD, González-Del Carmen M, Leyva-Gómez G. Alterations in mental health and quality of life in patients with skin disorders: a narrative review. Int J Dermatol 2022; 61: 783–791.
https://doi.org/10.1111/ijd.15852[AQ1] DOI: https://doi.org/10.1111/ijd.15852
Fasseeh AN, Elezbawy B, Korra N, Tannira M, Dalle H, Aderian S, et al. Burden of atopic dermatitis in adults and adolescents: a systematic literature review. Dermatol Ther 2022; 12: 2653–2668.
https://doi.org/10.1007/s13555-022-00819-6 DOI: https://doi.org/10.1007/s13555-022-00819-6
Obradors M, Blanch C, Comellas M, Figueras M, Lizan L. Health-related quality of life in patients with Psoriasis: a systematic review of the European literature. Qual Life Res 2016; 25: 2739–2754.
https://doi.org/10.1007/s11136-016-1321-7 DOI: https://doi.org/10.1007/s11136-016-1321-7
Ko SH, Chi CC, Yeh ML, Wang SH, Tsai YS, Hsu MY. Lifestyle changes for treating psoriasis. Cochrane Database Syst Rev 2019; 7: CD011972. DOI: https://doi.org/10.1002/14651858.CD011972.pub2
https://doi.org/10.1002/14651858.CD011972 DOI: https://doi.org/10.1002/14651858.CD011972
Carrascosa JM, Morillas-Lahuerta V. Comorbidities in atopic dermatitis: an update and review of controversies. Actas Dermosifiliogr (Engl Ed) 2020; 111: 481–486. DOI: https://doi.org/10.1016/j.adengl.2020.04.012
https://doi.org/10.1016/j.ad.2020.04.009 DOI: https://doi.org/10.1016/j.ad.2020.04.009
Dauden E, Blasco AJ, Bonanad C, Botella R, Carrascosa JM, González-Parra E, et al. Position statement for the management of comorbidities in psoriasis. J Eur Acad Dermatol Venereol 2018; 32: 2058–2073.
https://doi.org/10.1111/jdv.15177 DOI: https://doi.org/10.1111/jdv.15177
Elmets CA, Leonardi CL, Davis DMR, Gelfand JM, Lichten J, Mehta NN, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol 2019; 80: 1073–1113.
https://doi.org/10.1016/j.jaad.2018.11.058 DOI: https://doi.org/10.1016/j.jaad.2018.11.058
Balieva F, Schut C, Kupfer J, Lien L, Misery L, Sampogna F, et al. Perceived stress in patients with inflammatory and non-inflammatory skin conditions: an observational controlled study among 255 Norwegian dermatological outpatients. Skin Health Dis 2022; 2: e162.
https://doi.org/10.1002/ski2.162 DOI: https://doi.org/10.1002/ski2.162
Luna PC, Chu CY, Fatani M, Borlenghi C, Adora A, Llamado LQ, et al. (2023). Psychosocial burden of psoriasis: a systematic literature review of depression among patients with psoriasis. Dermatol Ther (Heidelb) 2023; 13: 3043–3055.
https://doi.org/10.1007/s13555-023-01060-5 DOI: https://doi.org/10.1007/s13555-023-01060-5
von Stülpnagel CC, Augustin M, Düpmann L, da Silva N, Sommer R. Mapping risk factors for cumulative life course impairment in patients with chronic skin diseases: a systematic review. J Eur Acad Dermatol Venereol 2021; 35: 2166–2184.
https://doi.org/10.1111/jdv.17348 DOI: https://doi.org/10.1111/jdv.17348
Andersen L, Nyeland ME, Nyberg F. Higher self-reported severity of atopic dermatitis in adults is associated with poorer self-reported health-related quality of life in France, Germany, the U.K. and the U.S.A. Br J Dermatol 2020; 182: 1176–1183.
https://doi.org/10.1111/bjd.18451 DOI: https://doi.org/10.1111/bjd.18451
Birdi G, Cooke R, Knibb RC. Impact of atopic dermatitis on quality of life in adults: a systematic review and meta-analysis. Int J Dermatol 2020; 59: e75–e91.
https://doi.org/10.1111/ijd.14763 DOI: https://doi.org/10.1111/ijd.14763
Puig L, Thom H, Mollon P, Tian H, Ramakrishna GS. Clear or almost clear skin improves the quality of life in patients with moderate-to-severe psoriasis: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2017; 31: 213–220.
https://doi.org/10.1111/jdv.14007 DOI: https://doi.org/10.1111/jdv.14007
Balato A, Zink A, Babino G, Buononato D, Kiani C, Eyerich K, et al. The impact of psoriasis and atopic dermatitis on quality of life: a literature research on biomarkers. Life (Basel) 2022; 12: 2026.
https://doi.org/10.3390/life12122026 DOI: https://doi.org/10.3390/life12122026
Fernández-Torres RM, Pita-Fernández S, Fonseca E. Quality of life and related factors in a cohort of plaque-type psoriasis patients in La Coruña, Spain. Int J Dermatol 2014; 53: e507–511.
https://doi.org/10.1111/ijd.12294 DOI: https://doi.org/10.1111/ijd.12294
Karpińska-Mirecka A, Bartosińska J, Krasowska D. The impact of hypertension, diabetes, lipid disorders, overweight/obesity and nicotine dependence on health-related quality of life and psoriasis severity in psoriatic patients receiving systemic conventional and biological treatment. Int J Environ Res Public Health 2021; 18: 13167.
https://doi.org/10.3390/ijerph182413167 DOI: https://doi.org/10.3390/ijerph182413167
Kwan Z, Bong YB, Tan LL, Lim SX, Yong ASW, Ch’ng CC, et al. Determinants of quality of life and psychological status in adults with psoriasis. Arch Dermatol Res 2018; 310: 443–451.
https://doi.org/10.1007/s00403-018-1832-x DOI: https://doi.org/10.1007/s00403-018-1832-x
Park SY, Kim KH. What factors influence on dermatology-related life quality of psoriasis patients in South Korea? Int J Environ Res Public Health 2021; 18: 3624.
https://doi.org/10.3390/ijerph18073624 DOI: https://doi.org/10.3390/ijerph18073624
Zhang XJ, Lin JR, Ou MX, Yan HW, Liu SN, Dai L, et al. Factors associated with quality of life in Chinese people with psoriasis: a cross-sectional study. BMC Public Health 2023; 23: 1860.
https://doi.org/10.1186/s12889-023-16758-6 DOI: https://doi.org/10.1186/s12889-023-16758-6
Iannone M, Janowska A, Panduri S, Morganti R, Davini G, Romanelli M, et al. Impact of psychiatric comorbidities in psoriasis, hidradenitis suppurativa and atopic dermatitis: the importance of a psychodermatological approach. Exp Dermatol 2022; 31: 956–961.
https://doi.org/10.1111/exd.14563 DOI: https://doi.org/10.1111/exd.14563
Lee SH, Lee SH, Lee SY, Lee B, Lee SH, Park YL. Psychological health status and health-related quality of life in adults with atopic dermatitis: a nationwide cross-sectional study in South Korea. Acta Derm Venereol 2018; 98: 89–97.
https://doi.org/10.2340/00015555-2797 DOI: https://doi.org/10.2340/00015555-2797
Charman CR, Venn AJ, Williams HC. The Patient-Oriented Eczema Measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients’ perspective. Arch Dermatol 2004; 140: 1513–1519.
https://doi.org/10.1001/archderm.140.12.1513 DOI: https://doi.org/10.1001/archderm.140.12.1513
Spuls PI, Gerbens LAA, Simpson E, Apfelbacher CJ, Chalmers JR, Thomas KS, et al. Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement. Br J Dermatol 2017; 176: 979–984.
https://doi.org/10.1111/bjd.15179 DOI: https://doi.org/10.1111/bjd.15179
Feldman SR, Mathias SD, Schenkel B, Colwell HH, McQuarrie K, Randazzo B, et al. Development of a patient-reported outcome questionnaire for use in adults with moderate-to-severe plaque psoriasis: the Psoriasis Symptoms and Signs Diary. J Dermatol Dermatol Surg 2016; 20: 19–26.
https://doi.org/10.1016/j.jdds.2015.07.004 DOI: https://doi.org/10.1016/j.jdds.2015.07.004
Mathias SD, Feldman SR, Crosby RD, Colwell HH, McQuarrie K, Han C. Measurement properties of a patient-reported outcome measure assessing psoriasis severity: the psoriasis symptoms and signs diary. J Dermatolog Treat 2016; 27: 322–327.
https://doi.org/10.3109/09546634.2015.1114567 DOI: https://doi.org/10.3109/09546634.2015.1114567
Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. AUDIT – The Alcohol Use Disorders Identification Test. Geneva: World Health Organization, 2001.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210–216. DOI: https://doi.org/10.1111/j.1365-2230.1994.tb01167.x
https://doi.org/10.1111/j.1365-2230
Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results. Br J Dermatol. 2008; 159: 997–1035.
https://doi.org/10.1111/j.1365-2133.2008.08832.x DOI: https://doi.org/10.1111/j.1365-2133.2008.08832.x
Löwe B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, et al. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord 2010; 122: 86–95.
https://doi.org/10.1016/j.jad.2009.06.019 DOI: https://doi.org/10.1016/j.jad.2009.06.019
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983; 24: 385–396. DOI: https://doi.org/10.2307/2136404
Klein EM, Brähler E, Dreier M, Reinecke L, Müller KW, Schmutzer G, et al. The German version of the Perceived Stress Scale: psychometric characteristics in a representative German community sample. BMC Psychiatry 2016; 16: 159.
https://doi.org/10.1186/s12888-016-0875-9 DOI: https://doi.org/10.1186/s12888-016-0875-9
Cohen J. A power primer. Psychol Bull 1992; 112: 155–159.
https://doi.org/10.1037//0033-2909.112.1.155 DOI: https://doi.org/10.1037//0033-2909.112.1.155
Ferrucci SM, Tavecchio S, Angileri L, Surace T, Berti E, Buoli M. Factors associated with affective symptoms and quality of life in patients with atopic dermatitis. Acta Derm Venereol 2021; 101: adv00590.
https://doi.org/10.2340/00015555-3922 DOI: https://doi.org/10.2340/00015555-3922
Mick A, Wecker H, Ziehfreund S, Maul JT, Biedermann T, Zink A. Cracking the code: unveiling the nexus between atopic dermatitis and addictive behavior: a cross-sectional exploration of risk factors. Arch Dermatol Res 2024; 316: 102.
https://doi.org/10.1007/s00403-024-02841-4 DOI: https://doi.org/10.1007/s00403-024-02841-4
van Acht MR, van den Reek JMPA, de Jong EMGJ, Seyger MMB. The effect of lifestyle changes on disease severity and quality of life in patients with plaque psoriasis: a narrative review. Psoriasis (Auckl) 2022; 12: 35–51. DOI: https://doi.org/10.2147/PTT.S294189
https://doi.org/10.2147/PTT.S29418
Nabieva K, Vender R. Quality of life and body region affected by psoriasis: a systematic review. Actas Dermosifiliogr 2023; 114: T33–T38. DOI: https://doi.org/10.1016/j.ad.2022.07.021
https://doi.org/10.1016/j.ad.2022.07.025 DOI: https://doi.org/10.1016/j.ad.2022.07.025
Shah V, Larson A, Jafferany M. Exploring the psychological impact of childhood-onset psoriasis: a systematic review. Clin Exp Dermatol 2024: llae276.
https://doi.org/10.1093/ced/llae276 DOI: https://doi.org/10.1093/ced/llae276
Stalder JF, Barbarot S, Wollenberg A, Holm EA, De Raeve L, Seidenari S, et al. Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe. Allergy 2011; 66: 1114–1121.
https://doi.org/10.1111/j.1398-9995.2011.02577.x DOI: https://doi.org/10.1111/j.1398-9995.2011.02577.x
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Carsten Spitzer, Ines Buchholz, Laura Lübke, Clara Wülfing, Katharina Meier, Georgios Kokolakis, Dennis Niebel, Caroline Mann, Ante Karoglan, Steffen Emmert, Alexander Thiem
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
